Daito Pharmaceutical

4577.TPharmaceutical

Filed as Daito Pharmaceutical Co.,Ltd. (2022-08–2026-08)

Major holders (5%+) · 1

Holder	Stake	Change	Filed
Kaname Capital, L.P.	12.13%	+1.00pp	2026-11-10

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 1

Massachusetts Financial Services Company 3.91% 2026-02-04

Ownership history · 6

Filed	Holder	Ratio	Change	Purpose
2026-02-04Amended	Massachusetts Financial Services Company2026-02-04 · amended	3.91%	new	Pure investment; Held for clients (discretionary / trust); Asset management / investment
2025-08-12Amended	Kaname Capital, L.P.2025-08-12 · amended	11.13%	+1.15pp	Pure investment
2024-08-22Amended	Kaname Capital, L.P.2024-08-22 · amended	9.98%	+3.26pp	Pure investment
2024-03-25Amended	Kaname Capital, L.P.2024-03-25 · amended	6.72%	-2.24pp	Pure investment
2024-01-31Amended	Kaname Capital, L.P.2024-01-31 · amended	8.96%	+1.12pp	Pure investment
2024-01-31Amended	Kaname Capital, L.P.2024-01-31 · amended	7.84%	new	Pure investment

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.